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1. Introduction 
The diagnosis of most liver diseases in children requires histological confirmation, thus liver 
biopsies are routine procedures in specialist centre. Although sensitive and relatively 
accurate blood tests used to detect and diagnose liver disease have now become widely 
available, percutaneous needle biopsy provides the histopathological examination and 
assessment of liver disease and remains the cornerstone in the evaluation and management 
of parenchymal liver diseases [1–5]. Paul Ehrlich is credited with performing the first 
percutaneous liver biopsy in 1883 in Germany. However, the technique required up to a 15-
minute intrahepatic phase, making it impractical and probably unsafe. In 1958, Menghini 
reported a new technique, which became more widely used  [5, 6]. Historically liver biopsy 
was used exclusively for adult patients, just in the last 50 years, following the developing 
knowledge in pediatric hepatology, it has taken on an important role in the clinical practice. 
In the past and even today many authors, discuss about when liver biopsy is recommended, 
regarding indications and timing. 
2. Indications for liver biopsy in children overview   
Actually numerous studies strongly suggest that due to the limitations and risks of biopsy, 
as well as the improvement of the diagnostic accuracy of new noninvasive biomarkers 
(Fibroscan, FibroTest, ELF) (7-14), liver biopsy should no longer be considered mandatory as 
a first line estimate of fibrosis in the most frequent chronic liver diseases. In reality even if 
the development of non-invasive markers of liver injury must be encouraged especially for 
the assessment of liver fibrosis,  the consensus in many conference statements recommend 
liver biopsy for the diagnosis and the management of almost all patients with liver diseases 
(15-18).  
To date liver biopsy has three major roles:  for diagnosis, for assessment of prognosis 
(disease staging), and/ or to assist in making therapeutic management decisions. 
As said, when to order a liver biopsy is a subject of contention in the medical community 
especially whether deciding to recommend a liver biopsy in a child.  
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Nearly all doctors agree that a liver biopsy should routinely ordered when tests reveal 
raised liver enzyme over several months. The liver enzyme elevation that merits a 
histological evaluation can range from 1.5 times to twice the normal range for a child of that 
weight and age. Considering the chronic trend of altered liver enzymes (almost 6 months) as 
one of the major indication, instead the acute flares of elevated enzymesin children often 
end to find a spontaneously resolution being related to some infections, fever or medical 
treatments.Diseases and situations in which liver biopsy may be indicated are listed in 
Tables 1. It is essential to have information about liver size and consistency and the presence 
of cyst or dilatated bile ducts from ultrasound, and if necessary to have a “spot”marked on 
the abdomento ensure an accurate biopsy. Correct information about coagulation 
parameters is crucial. Prothrombin time should be within 3 s of control values; platelets > 
80.000/ L. The patient’s blood group should be known, and it is prudent to cross-match a 
unit of blood prior to the procedure.However even when present an indication, liver biopsy 
could be difficult to perform because of clinical conditions of the patient. Abnormal 
coagulationis the main contraindications while in presence of ascitis different techniques 
other than the needle aspiration should be considered (table 2). In these cases when liver 
biopsy is strictly necessary alternative techniques will be used, such as transjugular biopsy 
and the procedure should be performed in high experienced centre (19-20).   
2.1 Use of liver biopsy in specific disease 
Neonatal cholestasis is a relevant condition in which liver biopsy play a pivotal role and has 
to be considered as soon as possible to provide specific treatment. In case of biliary atresia 
early diagnosis in vital, as the Kasai portoenterostomy is less likely to be successful the later 
is performed. Biliary atresia is the cause of liver disease in approximately 25% on infants 
presenting with neonatal cholestasis and percutaneous liver biopsy is essential and has high 
diagnostic specificity. Features of bile duct obstruction (duct reaction, previously known as 
ductular proliferation; bile plugs; portal tract edema) are usually obvious along with 
variable fibrosis and giant cell transformation (Figure 1). However the earlier the liver 
biopsy is performed, the more difficult it may be to interpret. Particularly in the setting of 
abnormal liver tests of unclear etiology, the risks and benefits of a liver biopsy should be 
carefully weighed, and the decision to perform a liver biopsy must be individualized. The 
liver biopsy plays a pivotal role in the follow-up of liver transplant (OLT). Pediatric liver 
transplant recipients often need to undergo liver biopsies for the detection and specification 
of complications such as acute or chronic graft rejection, infection, or drug toxicity. It is 
always necessary to have an histological confirmation (mixed inflammatory infiltrate in the 
portal tract with subendothelial lymphoid infiltration) (Figure 2). Some liver transplant 
programs perform liver biopsy on a protocol basis after transplantation (e.g., annually), 
even in those patients with normal liver tests, although compelling evidence to support this 
approach is lacking. In contrast, there is good evidence suggesting that fibrosis progression 
may be predicted by using liver histology in patients following transplantation (21-
23).Nevertheless when the medical history, physical examination, biochemical, serological, 
or  imaging investigation have shown the presence of  specific markers liver biopsy should 
be brought forward to ruled out liver diseases that need to be treated such as Wilson disease 
or autoimmune hepatitis (figure 3) or to make a diagnosis of non alcoholic steatohepatitis 
(figure 4). 
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Neonatal cholestatic jaundice 
 Abnormal liver tests of unknown etiology 
 Focal of diffuse abnormalities on imaging studies 
 Need of liver tissue to further analisys (Wilson disease, metabolic disorders) 
Prognosis—Staging of known parenchymal liver disease 
 Management—Developing treatment plans based on histologic analysis 
Suspicion of inherited metabolic liver disease 
 Suspicion of autoimmune liver disease 
 Liver transplant follow up 
 
Table 1. Indications for liver biopsy in children 
 
 
Absolute 
Severe coagulopathy (INR > 1,5, PLT < 50.000 mm3 )* 
  Possible vascular lesion 
  Treatment with FANS in the last week 
  Impossibility of blood transfusion, if necessary 
 Relative 
  Ascites 
  Obesity 
  Hemophilia* 
 
* possible in some cases with blood products transfusion 
 
Table 2. Contraindications to percutaneousliver biopsy in children 
 
 
 
Fig. 1. Liver histology of a patient with biliary atresia  
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Fig. 2. Liver transplant histology showing acute showing expansion of portal spaces, due to 
ductular rejection proliferation, bile plugging in bile ductules and giant cells 
 
 
 
Fig. 3. Histology of an autoimmune hepatitis, portal  
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Fig. 4. Liver histology in a children with non alcoholic and peryportal lymphoplasmocityc 
infiltrate  steatohepatitis 
2.2 Risks and complications  
Liver biopsy is generally regarded as a safe procedure, but an aspiration technique using a 
Menghini needle has a complication risk 1: 1000, while mortality rates up to 1:10,000 have 
been reported (24). The risks related to any procedure should always be balanced against 
potential benefits, and this is particularly pertinent in relation to children. Paediatric studies 
suggest an overall complication rate for percutaneous biopsy of 0.- 6.83% (2.4 – 4.5% major 
complications) (25-28). The data is difficult to compare between series as authors vary in 
their definition of major and minor complications, and in the exclusion criteria they employ. 
Complications include intraperitoneal haemorrhage, biliary peritonitis, haemobilia and 
injury to the duodenum, colon or lung. The risk of significant bleeding after an image-
guided percutaneous liver biopsy, as measured by a decrease in haematocrit, is reported to 
be up to 3%. Paediatric studies have shown that the risk of complications is greater in 
patients with malignant disease, cirrhosis or recent bone marrow.  It may be that these 
children should always be considered for a transjugular biopsy approach. Tumour seeding 
along the biopsy track remains a significant concern but unlike in hepatocellular carcinoma 
in the adult population, is rare in the commoner paediatric lesions such as hepatoblastoma. 
Smaller risks include lack of an adequate sample. With good operative technique, post-
operative pain should be minimal, and post-operative infection rare. It is important to 
remember that sick children  may deteriorate for clinical reasons unrelated to the liver 
biopsy itself. In table 3 are listed the rates of complications after needle biopsy as reported 
by D’Antiga and Mieli Vergani (29). The majority of complications occur in the first 3 hours 
after liver biopsy (30-35). 
The complications of this potentially dangerous procedures are much reduced if performed 
in experts hands in specialized units under controlled conditions. Especially for children is 
crucial a well established post procedure observation to early recognize possible 
complications. (tab 4) 
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Complications 
 
Rate % 
Pain 
Intraperitoneal haemorrhage 
Intrahepatic bleeding 
biliary peritonitis 
haemobilia 
Lung injury 
Anhestetic reaction 
Death 
 
0.056-22 
0.03-0.7 
0.059-23 
0.03-0.22 
0.059-0.2 
0.08-0.28 
0.029 
0.0083-0.03 
 
Table 3. Rate of complications after liver biopsy. From D’antiga L and Mi Vergani G in 
Training and Educational corner, Bollettino Sigemp, 2010. 
 
 
Blood pressure, pulse, respiration and temperature 
   15 min for   2h 
   30 min for   2h 
   Hourly for  2h 
   4 hourly as required 
Chest X-rat/ abdominal ultrasound may be required if bleeding if suspected 
 
Table 4. Post liver biopsy observation 
3. Liver biopsy procedure 
Several techniques may be used to obtain liver tissue; a table including/ defining specific 
terms has been provided in an effort to standardize terminology (Table 5).  
The liver biopsy should be performed in a dedicated area, with adequate space for the 
operator, assistants, emergency equipment if necessary, or for family members during 
recovery. 
All liver biopsy techniques require specific training so as to ensure appropriate-sized 
specimen retrieval and the lowest rate of complications. The main techniques are listed 
below: 
- Percutaneous or needle biopsy 
- Laparoscopic or open biopsy 
- Transjugular biopsy 
Percutanous Biopsy. This method may be undertaken in three different ways, namely 
palpation/ percussionguided, image-guided, and real-time image-guided. A 
palpation/ percussion-guided transthoracic approach, after infiltration of local anesthesia, is 
the classic percutaneous method. An aspiration technique with Menghini needle (or 
disposable variant) has a complication risk of 1 in 1000 biopsies. In fibrotic or chirrotic liver 
a Tru-Cut needle, which removes a larger core, may be necessary (Fig 5). The entry site is 
marked on the skin surface and the area is prepared and draped in sterile fashion. Local 
anesthetic is injected on the entry site. 
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Term Definition 
Liver biopsy Any type of liver biopsy 
Transthoracic 
palpation/ percussion  guided 
 
 
The most appropriate biopsy site is guided      
transcutaneous determined on t he basis of 
clinical examination. Traditionally used in 
practice. 
Transthoracic, imageguided 
 
 
The most appropriate biopsy site is  
determined or confirmed usually by    
ultrasound imaging before the biopsy 
Subcostal, image-guided 
 
This biopsy is accomplished in almost identical 
fashion as above, except that the approach is 
subcostal rather than transthoracic 
Transjugular Biopsy is accomplished through a jugular or femoral 
venous approach under fluoroscopic guidance 
 
Table 5. Liver Biopsy Terminology. From AASLD POSITION PAPER. Liver biopsy.2009 
 
 
 
 
Fig. 5. Menghini needle set (on the top), Tru-cut automatic needle (below) 
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The transthoracic approach with the routine use of ultrasound scan (US) as a guide to liver 
biopsy seems to be associated with reduced rate of complications and provides a higher 
diagnostic yield. Indeed in pediatric liver biopsies and aspirations, US is preferred as a 
guidance method over CT scan for its versatility, ability to image in real time, decreased 
cost, portability, and lack of ionizing radiation (36). In spite of the above evidence, some 
authors question the advantages of a real-time US-guided approach versus blinded biopsy 
in relation to pain, hypotension, bleeding and rate of subsequent hospitalization (37). 
Moreover the number of passes should limited to three or fewer whenever possible 
otherwise the risk of bleeding is higher. 
Surgical / laparoscopyc Biopsy. In some circumstances, a surgical approach is utilized 
because the liver is noted to be abnormal in appearance prior to planned surgery or at the 
time of surgery. Biopsy in this situation is performed either with typical needle devices or 
by wedge resection. Notably, the latter has been criticized as producing overestimates of 
fibrosis due to its proximity to the capsule. This technique of liver biopsy allows adequate 
tissue sampling under direct vision, with direct (and immediate) control of bleeding. It is 
generally performed by those with special expertise, typically under general anesthesia. 
Indeed a typical surgical approach (laparoscopic or open biopsy) for children  is 
considered  in case of suspected inherited metabolic liver disease in which more liver 
tissue is requested for molecular analysis and also muscle and skin biopsies are expected 
to reach a diagnosis.  
Beyond all the different techniques and in order to justify the risk in the procedure, it is 
essential that the resulting liver biopsy specimen be adequate so as to allow detailed 
interpretation. This almost always means that thebiopsy should be of large enough size to 
view a representative amount of parenchyma and number of portal tracts an adequate 
number of portal tracts has been proposed to be almost 10 for adult patients (38). However 
it’s clear as the sampling variability is almost inevitable due to the patchy  distribution of the 
disease especially in children(39). The size of specimen is essential especially to detect bile 
ducts or metabolic liver disease whereas less than 10 portal tracts could be enough to allow 
a diagnosis for viral hepatitis. Biopsy specimen should be obtained for routine 
histopatology, microbiology, electron microscopy, immunohistochemistry, and copper (if 
appropriate), and snap-frozen in liquid nitrogen for enzymatic or metabolic investigations. 
The interpretation of the histology may be difficult and requires considerable specialist 
expertise. 
Transvenous (Transjugular or Transfemoral) Biopsy. A number of specific situations 
warrant consideration of this approach. Patients with clinically demonstrable ascites; a 
known or suspected hemostatic defect; a small, hard, cirrhotic liver; morbid obesity with a 
difficult-to-identify flank site; or those in whom free and wedged hepatic vein pressure 
measurements are additionally being sought,  should be considered candidates to undergo 
liver biopsy by the transvenous route. Expertise is also important variableswhen 
considering transvenous biopsy. 
The technique has been well described in the literature and should be considered 
standard for adult patients (40-43) while is not routinely performed for children, therefore 
availability of local expertise is extremely important when considering transvenous 
biopsy. Hanafee and collegues first performed transjugular biopsy in 1967. Since that time 
the technique has been shown to be safe and effective in adults and children.In 1998 
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Bergey et al demonstrated that specimens of diagnostic quality could be obtained in 
children of all ages and sizes, even small infants (44). The theory behind transjugular liver 
biopsy is that instead of making a hole in liver capsule that can bleed externally, the hole 
is made in the wall of hepatic vein and any bleeding is internal, back to the vein. The risk 
of bleeding occurs only if somehow the anterior the anterior capsule of the liver is 
punctured during the transjugular biopsy, which can occur if the liver is small or the 
needle is placed too pheripherally.  
 
 
Fig. 6. Specimen of Liver obtained with needles and different techniques. All five biopsies 
shown in this figure were submitted for grading and staging of chronic hepatitis C. 
However, only (A) and (B) are felt to provide enough tissue for adequate histologic analysis. 
(C) is a fragmented specimen. (E) is a biopsy specimen 1.5 cm obtained with a 20-gauge 
needle. From AASLD POSITION PAPER. Liver biopsy.2009 
4. Conclusion 
The use of liver biopsy to obtain tissue for histological interpretation play a pivotal role in 
the practice and science of hepatology and remains a standard for diagnosis and treatment 
to which numerous other tests are held. Much has been learned about the pitfalls of 
sampling error and the need to obtain adequate samples so as to minimize this error and 
about which approaches and devices are most likely to produce good results in different 
patients.  
In terms of safety and comfort, it appears that the ultrasound guided approach improves 
certain outcomes, particularly in the hands of less experienced operators. This technology, 
long available in radiology units and increasingly available in liver/ endoscopy units, may 
also reduce the time needed to become proficient in biopsy but likely does not reduce the 
rate of postprocedure bleeding which, although infrequent, requires careful vigilance. 
Perhaps the use of non-invasive markers will be used in the future. For now, liver biopsy is 
useful andnecessary for the evaluation of chronic hepatopathies, despite the fact that it is not 
a perfect test. 
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